Report Feature
Patient Blood Management Market Trends and Forecast
The future of the global patient blood management market looks promising with opportunities in the blood bank, hospital, and diagnostic clinic and pathology lab markets. The global patient blood management market is expected to grow with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are ongoing technological advancements in blood diagnostics, hemostatic agents, and blood conservation devices, rising healthcare costs globally, and growing awareness among healthcare providers about the benefits of patient blood management.• Lucintel forecasts that instruments is expected to witness the highest growth over the forecast period.
• Within this market, hospitals is expected to witness the highest growth.
• APAC is expected to witness the highest growth over the forecast period.
Country Wise Outlook for the Patient Blood Management Market
• United States: Haemonetics Corporation has partnered with hospitals to implement comprehensive patient blood management programs, focusing on blood conservation strategies and reducing transfusion rates.
• Germany: Terumo BCT GmbH has launched educational campaigns in collaboration with healthcare providers to raise awareness about patient blood management techniques, emphasizing the use of blood components judiciously.
• Australia: The Australian Red Cross Blood Service has introduced new guidelines for blood management in hospitals, advocating for evidence-based practices to minimize unnecessary transfusions. Australian healthcare facilities aim to achieve national targets for reducing transfusion rates through systematic blood conservation programs.
• Japan: Mitsubishi Tanabe Pharma Corporation has developed advanced blood management systems integrated with artificial intelligence to optimize transfusion decisions based on patient-specific data. A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Patient Blood Management Market by Segment
The study includes a forecast for the global patient blood management market by product, component, end use, and region.Patient Blood Management Market by Product [Value from 2018 to 2030]:
• Instruments
• Accessories
• Reagents and Kits
• Software
Patient Blood Management Market by Component [Value from 2018 to 2030]:
• Whole Blood and Red Blood Cells
• Plasma
Patient Blood Management Market by End Use [Value from 2018 to 2030]:
• Blood Banks
• Hospitals
• Diagnostic Clinics and Pathology Labs
Patient Blood Management Market by Region [Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Patient Blood Management Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies patient blood management companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the patient blood management companies profiled in this report include-• Asahi Kasei Corporation
• B. Braun SE
• BioMérieux
• Grifols, S.A.
• Haemonetics Corporation
• Haier Biomedical
• Immucor
• LivaNova
• Macopharma
• Terumo Corporation
Recent Development in the Patient Blood Management Market
• Haemonetics Corporation: Haemonetics has introduced the TEG® 6s Hemostasis Analyzer System, designed to provide comprehensive viscoelastic testing for managing bleeding and thrombotic risk in patients. This system helps healthcare providers optimize patient blood management strategies by providing real-time data on clot formation dynamics.
• Terumo Corporation: Terumo has launched the Spectra Optia® Apheresis System with therapeutic plasma exchange capabilities, supporting patient blood management by facilitating the removal of harmful substances from the blood while preserving essential components. This system is utilized in various therapeutic applications to improve patient outcomes.
• Fresenius Kabi: Fresenius Kabi has expanded its portfolio of transfusion and infusion therapies with innovative blood management solutions, including leukoreduction filters and blood bags designed to maintain blood quality and minimize the risk of transfusion reactions. These products enhance patient safety and transfusion efficacy.
• Baxter International Inc.: Baxter has developed the Amia Automated Peritoneal Dialysis System, which integrates patient blood management principles by providing continuous renal replacement therapy. This system helps manage fluid and electrolyte balance in critically ill patients while minimizing the need for blood transfusions.
• Bio-Rad Laboratories: Bio-Rad Laboratories has introduced the IH-500 Hematology Analyzer, incorporating advanced technology for complete blood count (CBC) testing. This analyzer supports patient blood management by providing accurate hematological parameters, enabling healthcare providers to monitor and manage patients' blood status effectively.
Features of the Global Patient Blood Management Market
Market Size Estimates: Patient blood management market size estimation in terms of value ($B). Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions. Segmentation Analysis: Patient blood management market size by product, component, end use, and region in terms of value ($B). Regional Analysis: Patient blood management market breakdown by North America, Europe, Asia Pacific, and Rest of the World. Growth Opportunities: Analysis of growth opportunities in different products, components, end uses, and regions for the patient blood management market. Strategic Analysis: This includes M&A, new product development, and competitive landscape of the patient blood management market. Analysis of competitive intensity of the industry based on Porter’s Five Forces model.FAQ
Q1. What is the growth forecast for patient blood management market? Answer: The global patient blood management market is expected to grow with a CAGR of 6.5% from 2024 to 2030. Q2. What are the major drivers influencing the growth of the patient blood management market? Answer: The major drivers for this market are ongoing technological advancements in blood diagnostics, hemostatic agents, and blood conservation devices, rising healthcare costs globally, and growing awareness among healthcare providers about the benefits of patient blood management. Q3. What are the major segments for patient blood management market? Answer: The future of the patient blood management market looks promising with opportunities in the blood bank, hospital, and diagnostic clinic and pathology lab markets. Q4. Who are the key patient blood management market companies? Answer: Some of the key patient blood management companies are as follows:• Asahi Kasei Corporation
• B. Braun SE
• BioMérieux
• Grifols, S.A.
• Haemonetics Corporation
• Haier Biomedical
• Immucor
• LivaNova
• Macopharma
• Terumo Corporation Q5. Which patient blood management market segment will be the largest in future? Answer: Lucintel forecasts that instruments is expected to witness the highest growth over the forecast period. Q6. In patient blood management market, which region is expected to be the largest in next 5 years? Answer: APAC is expected to witness the highest growth over the forecast period. Q7. Do we receive customization in this report? Answer: Yes, Lucintel provides 10% customization without any additional cost.
Table of Contents
Methodology
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
Key Questions
- • What are some of the most promising, high-growth opportunities for the patient blood management market by product (instruments, accessories, reagents and kits, and software), component (whole blood and red blood cells and plasma), end use (blood banks, hospitals, and diagnostic clinics and pathology labs), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
- • Which segments will grow at a faster pace and why?
- • Which region will grow at a faster pace and why?
- • What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
- • What are the business risks and competitive threats in this market?
- • What are the emerging trends in this market and the reasons behind them?
- • What are some of the changing demands of customers in the market?
- • What are the new developments in the market? Which companies are leading these developments?
- • Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
- • What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
- • What M&A activity has occurred in the last 5 years and what has its impact been on the industry? For any questions related to Patient Blood Management Market Market, Patient Blood Management Market Market Size, Patient Blood Management Market Market Growth, Patient Blood Management Market Market Analysis, Patient Blood Management Market Market Report, Patient Blood Management Market Market Share, Patient Blood Management Market Market Trends, Patient Blood Management Market Market Forecast, Patient Blood Management Market Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
